Ustekinumab is a medication used to manage and treat a variety of inflammatory conditions, including psoriasis, psoriatic arthritis, and inflammatory bowel disease. It is in the monoclonal antibody class of medications. This activity reviews the indications, action, and contraindications for ustekinumab as a valuable agent in treating inflammatory diseases. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the interprofessional team in the management of psoriasis, psoriatic arthritis, and inflammatory bowel disease.

**Objectives:**
- Explain the mechanism of action of ustekinumab.
- Describe the indications for the use of ustekinumab.
- Review the potential adverse event that can accompany ustekinumab use.
- Outline strategies utilized by healthcare teams to improve care coordination and communication when ustekinumab is being administered.